New combo aims to reboot immune system against tough melanoma
Disease control
Terminated
This study tested a combination of two drugs, duvelisib (a pill) and nivolumab (an IV infusion), for people with advanced melanoma that could not be removed by surgery and had gotten worse despite standard immunotherapy. The goal was to see if adding duvelisib could help the immu…
Phase: PHASE1, PHASE2 • Sponsor: John Kirkwood • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC